Literature DB >> 12637257

Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats.

Mary A Selak1, Bayard T Storey, Iyalla Peterside, Rebecca A Simmons.   

Abstract

Intrauterine growth retardation (IUGR) has been linked to the development of type 2 diabetes in later life. We have developed a model of uteroplacental insufficiency, a common cause of intrauterine growth retardation, in the rat. Early in life, the animals are insulin resistant and by 6 mo of age they develop diabetes. Glycogen content and insulin-stimulated 2-deoxyglucose uptake were significantly decreased in muscle from IUGR rats. IUGR muscle mitochondria exhibited significantly decreased rates of state 3 oxygen consumption with pyruvate, glutamate, alpha-ketoglutarate, and succinate. Decreased pyruvate oxidation in IUGR mitochondria was associated with decreased ATP production, decreased pyruvate dehydrogenase activity, and increased expression of pyruvate dehydrogenase kinase 4. Such a defect in IUGR mitochondria leads to a chronic reduction in the supply of ATP available from oxidative phosphorylation. Impaired ATP synthesis in muscle compromises energy-dependent GLUT4 recruitment to the cell surface, glucose transport, and glycogen synthesis, which contribute to insulin resistance and hyperglycemia of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637257     DOI: 10.1152/ajpendo.00322.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  52 in total

1.  Alteration of mitochondrial function in adult rat offspring of malnourished dams.

Authors:  Brigitte Reusens; Nicolas Theys; Claude Remacle
Journal:  World J Diabetes       Date:  2011-09-15

2.  Effects of dietary methionine restriction on postnatal growth, insulin sensitivity, and glucose metabolism in intrauterine growth retardation pigs at 49 and 105 d of age.

Authors:  Zhixiong Ying; Xiaoke Ge; Hao Zhang; Weipeng Su; Yue Li; Le Zhou; Lili Zhang; Tian Wang
Journal:  J Anim Sci       Date:  2019-02-01       Impact factor: 3.159

3.  Maternal nutrient restriction affects properties of skeletal muscle in offspring.

Authors:  Mei J Zhu; Stephen P Ford; Warrie J Means; Bret W Hess; Peter W Nathanielsz; Min Du
Journal:  J Physiol       Date:  2006-06-08       Impact factor: 5.182

4.  The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscle.

Authors:  B S Muhlhausler; J A Duffield; S E Ozanne; C Pilgrim; N Turner; J L Morrison; I C McMillen
Journal:  J Physiol       Date:  2009-07-21       Impact factor: 5.182

5.  Antenatal corticosteroids alter insulin signaling pathways in fetal baboon skeletal muscle.

Authors:  Cynthia L Blanco; Alvaro G Moreira; Lisa L McGill-Vargas; Diana G Anzueto; Peter Nathanielsz; Nicolas Musi
Journal:  J Endocrinol       Date:  2014-04-22       Impact factor: 4.286

Review 6.  Fetal programming and cardiovascular pathology.

Authors:  Barbara T Alexander; John Henry Dasinger; Suttira Intapad
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

Review 7.  I'm eating for two: parental dietary effects on offspring metabolism.

Authors:  Oliver J Rando; Rebecca A Simmons
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

8.  Maternal obesity downregulates myogenesis and beta-catenin signaling in fetal skeletal muscle.

Authors:  Jun F Tong; Xu Yan; Mei J Zhu; Stephen P Ford; Peter W Nathanielsz; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-27       Impact factor: 4.310

Review 9.  From Mice to Men: research models of developmental programming.

Authors:  C Rabadán-Diehl; P Nathanielsz
Journal:  J Dev Orig Health Dis       Date:  2013-02       Impact factor: 2.401

10.  Heat shock protein 70 is upregulated in the intestine of intrauterine growth retardation piglets.

Authors:  Xiang Zhong; Tian Wang; Xuhui Zhang; Wei Li
Journal:  Cell Stress Chaperones       Date:  2009-10-15       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.